Whitney Purvis, 33, was being held without bond in the Floyd County Jail in Rome, Georgia, about 65 miles (105 kilometers) northwest of Atlanta, according to online jail records.

CRISPR Therapeutics CRSP and Intellia Therapeutics NTLA are leading developers of therapies that utilize the Nobel ...

15. Alpha-1 Antitrypsin Deficiency Key Products 16. Dormant and Discontinued Products 17. Alpha-1 Antitrypsin Deficiency Unmet Needs 18. Alpha-1 Antitrypsin Deficiency Future Perspectives 19.

Beam recently announced the clearance of its investigational drug application (IND) for BEAM-302 by the United States (U.S.) Food and Drug Administration (FDA), enabling the company to activate ...

About Alpha-1 Antitrypsin Deficiency (AATD) AATD is an inherited genetic disorder that can cause early onset emphysema and liver disease. The most severe form of AATD arises when a patient has a point ...

U.S. IND Represents Regulatory Clearance For BEAM-302 Spanning Six Countries and Second Open IND for a Beam In Vivo Base Editing Program in the U.S. CAMBRIDGE, Mass., March 27, 2025 (GLOBE NEWSWIRE) ...

Beam Therapeutics Announces Clearance of Investigational New Drug Application for BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD) by the United States (U.S.) Food and Drug ...

1,290 +4,88 % +0,060 Branche Biotechnologie Aktienmarkt NASDAQ Biotech 1-Jahres-Chart 5-Tage-Chart Nachrichten Analysen Kurse Chart GlobeNewswire (Europe) 18.03.2025 12:06 Uhr 130 Leser Artikel ...

Prime Editing is positioned as a potentially best-in-class approach for treating alpha-1 antitrypsin deficiency (AATD), showcasing the company's innovative gene editing capabilities.